摘要:
A process is disclosed for the preparation of β-hydroxy-γ-trimethylamino-butyric acid (L-carnitine) wherein a) the compound diketene having formula: is reacted with chlorine, and the chlorination product thus obtained is submitted to amidation by the methylester of an optically-active aminoacid, having formula: wherein R = CH 2 A r or A r is a substitued or not- substituted aromatic group, to yield the compound 4-chloro-3-ketobutyrylamide of the methylester of the optically-active aminoacid: wherein R has the above reported meaning, b) the compound (IV) is reduced in the presence of a reducing agent to yield the compound wherein R has the above reported meaning, in the form of a mixture of (3R)-4-chloro-3-hydrox- ybutyrylamide of the methylester of an optically-active acid (VI), and (3S)-4-chloro-3-hydrox- ybutyrylamide of the methylester of an optically active aminoacid (VII), c) the compound (3R)-4-chloro-3-hydrox- ybutyrylamide of the methylester of an optically-active aminoacid (VI) is separated and recovered from the reduction reaction product, d) the compound (VI) is submitted to methanolysis by hydrogen chloride gas in methanol, e) the methylester of the optically-active aminoacid (III) is precipitated and recovered from the methanolysis reaction product, f) from the mother liquors the compound methylester of (3R)-4-chloro-3-hydroxybutyric acid having formula is recovered, g) the compound (VIII) thus obtained is treated with trimethylamine in ethanol, is hydrolyzed with hydro chloric acid and the compound L-carnitine (I) is separated and recovered.
摘要:
Retro-inverted peptides, analogues of Bradykinin Poten- (I) tiator Pentapeptide (BPP 5a ), definable by the general formula useful as antihypertensives and diagnostics.
摘要:
Nouvelle héparine dépolymérisée et supersulfatée ayant un poids moléculaire compris entre 2000 et 9000 et un degré de sulfatation d'au moins 2,5, dans laquelle tous les hydroxyles primaires sont sulfatés ; procédé pour sa préparation par réaction d'une héparine d'origine naturelle ou d'une de ses fractions avec un mélange acide sulfurique/acide chlorosulfonique ; et compositions pharmaceutiques à action antithrombotique potentielle, hypolipémiante et fibrinolytique utiles pour la prévention de la thrombrose et le traitement de l'athérosclérose.
摘要:
Nucleic acid and protein compositions are provided from B. pertussis which may find use in diagnosis, prevention and therapy of whooping cough. Particularly, an open reading frame encoding filamentous hemagglutinin precursors provided, with the intact protein for the filamentous hemagglutinin portion thereof, can be expressed in a wide variety of hosts, for use in the production of antibodies, for immunodiagnosis or therapy, or as vaccines for prophylactic purposes.
摘要:
It is described a process for the extraction and following purification of alfa1-antitrypsin (alfa1-pI) from Cohn IV-1 Fraction, such process comprising the following steps:
a) solubilization of the starting paste constituted by Cohn IV-1 Fraction and fractioned precipitation; b) hydrophobic interaction chromatography; c) viral inactivation; and d) final operations.
摘要:
A process for the extraction of Factor VIII - von Willebrand Factor (FVIII:C - FvW) complex from total human plasma is described, comprising unfreezing the plasma at room temperature after stabilization, selective absorption on anionic exchanger of factors constituting the protrombinic complex, extraction, on anionic exchanger as well, of Factor VIII - von Willebrand Factor (FVIII:C - FvW) complex and a further purification by means of a cationic exchanger of FVIII:C - FvW suitably stabilized and inactivated.
摘要:
A description is given of a process for the purification of factor IX, factor X, and factor II from human plasma or fractions thereof, wherein a solution containing prothrombin complex factors is purified by repeated ion exchange chromatographic separations followed by adsorption chromatography on metal ions.
摘要:
There is described a genetic vector for stable integration, by homologous recombination, of specific DNA sequences into the genome of the yeasts Kluyveromyces lactis and Saccharomyces cerevisiae which allows high number multiple integration events to be obtained and plasmids containing the same.